Our people are our strength. And, together with over 56,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing

Sectors: Animal Health Pharmaceutical

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

Tags: CAC40 Sectors: Pharmaceutical

KPMG is a global network of professional firms providing Audit, Tax and Advisory services. We have 227,000 outstanding professionals working together to deliver value in 146 countries and territories. With a worldwide presence, KPMG continues to build on our successes thanks to clear vision, defined values and, above all, our people. Our industry focus helps KPMG firms’ professionals develop a rich understanding of clients'​ businesses and the insight, skills and resources required to address industry-specific issues and opportunities. The independent member firms of the KPMG network are affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. Each KPMG firm …

Sectors: Consulting, audit

Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and …

Sectors: French Cluster Public business cluster

[Automatic translation follows] Catalyst of innovation & Business accelerator in BFC A competitiveness hub since 2005, the PMT catalyzes innovation, accelerates business and supports the transitions of industries in Burgundy-Franche-Comté. Since 2017, it has brought together, through its PMT Santé and PMT ASD clusters, the sectors of health technologies on the one hand and aeronautics-space-defense on the other, resulting from excellence in microtechnology. It has also developed strong expertise in supporting start-ups and innovative companies through its PMT Propulseur accelerator. Microtechnology, Health, Aeronautics, Defense, Space, Precision mechanics, Luxury, Innovation, International, Labeling, Training, Medical, Burgundy-Franche-Comté, and Precision mechanics

Sectors: French Cluster Public business cluster

Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: …

Sectors: Biotechnology Startup accelerator & VC

[Automatic translation follows] First economic and financial information channel in France. BFM Business TV is the leading economic and financial news channel in France. It is distinguished by programming centered on the search for expertise. Programs on economic news have established themselves as economic news events. “Good Morning Business” for example, offers on its guest set the latest innovations, editorials and information on underlying trends. BFM Business TV is also available live on our website as well as on an application dedicated to it. Tech, Stock Market, Economy, Real Estate, Business, Automobile, and High-Tech

Sectors: Media

French association of investors for growth Founded in 1984, France Invest is the industry association representing French private equity professionals. Its role is to promote this asset class to institutional investors, this funding method and support to entrepreneurs, and this leading economic sector to opinion leaders and public authorities. The association itself is home to 359 asset management companies and nearly 200 associate members from all the business lines that support and advise investors and entrepreneurs in setting up and managing their partnerships. Our membership supports and finances more than 7,700 of the most dynamic startups, SMEs and mid-caps, employing …

Sectors: Startup accelerator & VC

[Automatic translation follows] The DGE designs and implements policies to promote competitiveness and business growth. The General Directorate of Enterprises serves the Minister responsible for the Economy and Finance. Our action is at the heart of the Government's projects in favor of the economic transformation and strategic autonomy of the country. Serving business competitiveness, it carries industrial policy, defines digital regulation measures, as well as policies to support the local economy. It supports companies in the digital and ecological transformation of the economy, and works in favor of regulatory simplification and an ambitious innovation policy. Its missions include both a …

Sectors: National and local authorities

[Automatic translation follows] Tech for all, for good French Tech Grand Paris is the Ile-de-France community of start-ups, investors, corporates and community builders. It represents a collective of entrepreneurs, investors and tech leaders created to represent the 8,000+ startups present in the region, and to carry the voice of an ecosystem which concentrates 70% of Tech metrics. It activates it through numerous events (Commande Publique, Tech Days, Gen AI, Health Innovative Intensive Training, etc.), brings together the many players present in Greater Paris, and deploys national French Tech programs there (Tremplin, Central, Rise, I Choose French Tech...).

Sectors: French Tech

La French Tech désigne tous les acteurs de l’écosystème de start-up françaises, soutenu par la Mission French Tech. 🇫🇷 La French Tech est la marque déployée par l’Etat français qui représente l’écosystème de 25 000 start-up français et de tous les acteurs qui gravitent autour (fonds d’investissement, associations, acteurs publiques, etc.), soutenu par la Mission French Tech (administration rattachée à la Direction Générale des Entreprises, au sein du ministère de l’Economie, des Finances et de la Souveraineté industrielle et numérique). Elle a pour mission d’accompagner le développement de l’écosystème French Tech, mouvement français des start-up technologiques innovantes, dans la lignée …

Sectors: Media

[Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies, from start-up to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region adapted to each stage of the life of companies. As a partner bank for entrepreneurs, Bpifrance supports them over the long term to support their growth and competitiveness. The teams are at the heart of the regions, throughout the territory, through more than 50 regional locations. Financing SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee

Sectors: Bank

We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, and Primary Care

Sectors: Pharmaceutical

Building a collaborative ecosystem that leverages the power of deep technologies to tackle world challenges. Hello Tomorrow was created in 2011 by a group of individuals convinced that science and technology need to form part of a toolkit of solutions to change our industries, sustain a growing population and help solve global crises. But the traditional model of technology transfer to bring solutions from lab to market, and from idea to impact, could not rise to this challenge. In turn, Hello Tomorrow has built, and now animates, a global ecosystem that facilitates ‘deep tech’ innovation through multiple activities. Over the …

Sectors: Trade show

[Automatic translation follows] Welcome to the page of the Ministry of Economy, Finance and Industrial and Digital Sovereignty Within the Ministry, more than 135,000 agents today put their talent at the service of a strong and sustainable economy in the region and in Paris. User service, legal affairs, economic development, performance management... more than 160 professions are carried out in the Bercy administrations. The diversity of these sectors of activity makes it possible to build rich career paths adapted to each person’s profiles. How to reach Bercy services? Each year, the ministry recruits 5,000 women and men. Numerous competitions of …

We have merged with Bristol Myers Squibb creating a leading biopharma company, ideally positioned to discover, develop and deliver innovative medicines for patients fighting serious diseases. Visit www.bms.com to continue to learn more about our work to produce the next generation of medicines to treat cancer and other serious diseases. For more information on the acquisition, see our press release at: http://bit.ly/3UbQcnl Hematology, Oncology, Inflammation, Immunology, Cancer, R&D, Innovation, Immunooncology, biopharma, Epigenetics, Protein Homeostasis, Translation Medicine, and Orphan diseases

Sectors: Pharmaceutical

We advance science so that we all have more time with the people we love. Are you ready to join us? Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is …

Sectors: Biotechnology Pharmaceutical

Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Sectors: Biotechnology Pharmaceutical

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy

Sectors: Pharmaceutical

What science can do We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business

Sectors: Pharmaceutical

[Automatic translation follows] Share the economy. Associating the expertise of a historical title to the agility of digital, the Tribune has operated for several years its transformation, deploying at the heart of the uses of its audience: website, digital daily, mobile applications, social networks, butAlso a field presence to animate its audience via the organization of 80 events per year.Its territorial anchor makes the tribune the economic media of metropolises with editions in regions and Africa with the African gallery, fueling an editorial line focused on the real economy (innovation, digital, territories ...) and enhance thecompanies that boost their ecosystem.

Sectors: Media